| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $123K | -61.2% | +108.5% |
| Cost of Revenue | $112K | -62.9% | +60.0% |
| R&D Expense | $655K | -6.0% | +17.6% |
| SG&A Expense | $1.0M | -9.2% | -9.0% |
| Operating Income | -$1.7M | +6.5% | +7.8% |
| Net Income | -$1.7M | +6.7% | +8.6% |
| EPS (Basic) | -$0.10 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.3M | +67.8% | -63.3% |
| Accounts Receivable | $3K | -40.0% | +200.0% |
| Inventory | $22K | -18.5% | -80.5% |
| Current Assets | $1.6M | +45.7% | -59.1% |
| Total Assets | $2.5M | +19.1% | -52.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.2M | — | — |
| Financing Cash Flow | $2.0M | — | — |
| +9.1% |
| +16.7% |
| $876K |
| -28.8% |
| -29.8% |
| Total Liabilities | $992K | -27.9% | -32.6% |
| Stockholders' Equity | $1.6M | +104.2% | -59.5% |